Blood-brain barrier permeability of normal-appearing white matter in patients with vestibular schwannoma: A new hybrid approach for analysis of T(1) -W DCE-MRI

前庭神经鞘瘤患者正常外观白质的血脑屏障通透性:一种用于分析T1加权DCE-MRI的新型混合方法

阅读:1

Abstract

PURPOSE: To develop and assess a "hybrid" method that combines a first-pass analytical approach and the Patlak plot (PP) to improve assessment of low blood-brain barrier permeability from dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) data. MATERIALS AND METHODS: Seven patients with vestibular schwannoma were enrolled. T(1) -W DCE imaging was acquired on a 1.5T scanner. Normal-appearing white matter (NAWM) was divided into four regions of interest (ROIs) based on the magnitude of changes in longitudinal relaxation rate (ΔR1) after gadolinium administration. Kinetic analysis of ROI-averaged contrast agent concentration curves was performed using both the conventional PP and the hybrid method. Computer simulated uptake curves that resemble those from NAWM were analyzed with both methods. Percent deviations (PD) of the "measured" values from the "true" values were calculated to evaluate accuracy and precision of the two methods. RESULTS: The simulation showed that, at a noise level of 4% (a noise level similar to the in vivo data) and using a signal intensity (SI) averaging scheme, the new hybrid method achieved a PD of 0.9 ± 2.7% for v(p) , and a PD of -5.4 ± 5.9% for K(trans) . In comparison, the PP method obtained a PD of 3.6 ± 11.3% for v(p) , and -8.3 ± 12.8% for K(trans) . One-way analyses of variance (ANOVAs) showed significant variations from the four WM regions (P < 10(-15) for ΔR1; P < 10(-6) for K(trans) ; P < 10(-4) for v(p) ). CONCLUSION: Both computer simulation and in vivo studies demonstrate improved reliability in v(p) and K(trans) estimates with the hybrid method. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 1 J. MAGN. RESON. IMAGING 2017;46:79-93.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。